STRUCTURE ELUCIDATION OF 2 DIPHENYLHYDANTOIN DERIVATIVES VIA H-1 AND C-13 NMR-SPECTROSCOPY

被引:3
作者
CIECHANOWICZRUTKOWSKA, M
RAGONA, L
GRECO, F
ZETTA, L
PEGNA, M
机构
[1] CNR,IST CHIM MACROMOLEC,NMR LAB,I-20133 MILAN,ITALY
[2] JAGIELLONIAN UNIV,REG PHYSICOCHEM ANAL & STRUCT RES LAB,PL-30060 KRAKOW,POLAND
[3] CNR,IST CHIM MACROMOLEC,NMR LAB,TECHNOBIOLCHIP,I-20133 MILAN,ITALY
[4] CNR,IST CHIM MACROMOLEC,NMR LAB,ITALFARMACO,I-20133 MILAN,ITALY
关键词
H-1; NMR; AMPHIPATHIC STRUCTURE; DIPHENYLHYDANTOIN DERIVATIVES; ANTICONVULSANTS; ANTIDEPRESSANT;
D O I
10.1002/mrc.1260330716
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The solution conformations of 1-benzyl-5,5-diphenyl-2,4-dioxo-3-imidazolidineacetic acid (AC) and 3-(2,4-dichlorobenzyl)-5,5-diphenyl-2,4-dioxo-1-imidazolidine acetic acid (AD) were studied by proton and carbon NMR spectroscopy. The two drugs have different pharmacological activities, AC having anticonvulsant and AD having antidepressant but no anticonvulsant properties. The relative orientations of the hydantoin ring substituents were investigated and are discussed in terms of amphipathic distribution of polar and apolar domains.
引用
收藏
页码:586 / 591
页数:6
相关论文
共 7 条
[1]   BLOCKADE OF CARDIAC SODIUM-CHANNELS BY AMITRIPTYLINE AND DIPHENYLHYDANTOIN - EVIDENCE FOR 2 USE-DEPENDENT BINDING-SITES [J].
BARBER, MJ ;
STARMER, CF ;
GRANT, AO .
CIRCULATION RESEARCH, 1991, 69 (03) :677-696
[2]  
BODENHAUSEN G, 1982, MOL PHYS, V65, P319
[3]  
CIECHANOWICZRUT.M, 1994, ACTA CRYSTALLOGRAP B, V0050
[4]   COMBINED SUPPRESSION OF DIAGONAL PEAKS AND T1 RIDGES IN TWO-DIMENSIONAL NUCLEAR OVERHAUSER ENHANCEMENT SPECTRA [J].
DENK, W ;
WAGNER, G ;
RANCE, M ;
WUTHRICH, K .
JOURNAL OF MAGNETIC RESONANCE, 1985, 62 (02) :350-355
[5]   CALCULATION OF NUCLEAR MAGNETIC RESONANCE SPECTRA OF AROMATIC HYDROCARBONS [J].
JOHNSON, CE ;
BOVEY, FA .
JOURNAL OF CHEMICAL PHYSICS, 1958, 29 (05) :1012-1014
[6]   COMPETITION FOR DIAZEPAM RECEPTOR-BINDING BY DIPHENYLHYDANTOIN AND ITS ENHANCEMENT BY GAMMA-AMINOBUTYRIC ACID [J].
TUNNICLIFF, G ;
SMITH, JA ;
NGO, TT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 91 (03) :1018-1024
[7]  
ZEJC A, 1989, POL J PHARMACOL PHAR, V41, P483